Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen) Übersicht
| ||||||||||||||||||
Abbildung 13: Telmisartan - Valsartan The results of a study comparing the effects of telmisartan (40–80 mg) with valsartan (80–160 mg) on BP in the last 6 hours of the dosing interval are shown here.1 Telmisartan was superior to valsartan at reducing DBP and SBP at the end of the dosing interval. 1. White WB, et al. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure. Impact on the early morning period. Am J Hypertens 2004; 17: 347–353. |
Abbildung 13: Telmisartan - Valsartan
The results of a study comparing the effects of telmisartan (40–80 mg) with valsartan (80–160 mg) on BP in the last 6 hours of the dosing interval are shown here.1 Telmisartan was superior to valsartan at reducing DBP and SBP at the end of the dosing interval. 1. White WB, et al. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure. Impact on the early morning period. Am J Hypertens 2004; 17: 347–353. |